Zhou, H., Zhao, H., Hou, X., Wang, Y., He, Z., Li, Y., Ma, Y., Zhao, Y., Huang, Y., Chen, L., Xiao, S., Zhu, H., Zhu, Y., Fang, W., Zhang, L., Yang, Y. (2026). Izalontamab Brengitecan in Locally Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01929